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Abstract: 
In aspiring to become a true engineering discipline for the biological sciences, the field of synthetic 
biology has a unique opportunity to create and encourage the widespread adoption of standards to 
enhance innovation and social impact in the field. This article presents a study of the standards setting 
efforts by the institutions, firms, governments, and individuals within the field of synthetic biology. 
 
Numerous standards have been proposed in synthetic biology, including those relevant to structure, 
function, description, measurement, data, information exchange, software, biosafety and biosecurity, and 
even law. At the present time, the adoption of technical standards has been relatively modest and no one 
technical standard appears to have dominated the field. Standards covering policies in biosecurity, by 
comparison, are more firmly established and biosecurity practices governing commercial orders for 
synthetic DNA have been widely adopted. Among standards-setting groups within the synthetic biology 
community, most have expressed a preference that standards remain open and accessible to the 
community as a whole. Recent developments, including the U.S. Supreme Court's decision in AMP v. 
Myriad and the Leahy-Smith America's Invents Act, could help give greater clarity to the scope of patent 
rights covering innovations and standards in synthetic biology. Copyright and trademark may provide 
alternatives mechanisms for conferring rights in synthetic biology inventions, setting and reinforcing 
standards, or promoting open innovation. 
 
Whether formal policies requiring the disclosure and licensing of property rights covering technical 
standards could be made mandatory or would ultimately be beneficial to the field of synthetic biology 
remain open questions. What is certain is that the synthetic biology community is unusually attuned to 
debates surrounding intellectual property and standards setting, and views its engagement in these debates 
as vital to ensure the continued success of synthetic biology. 
